Clinical Trial Update: A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial RAPID2 evaluating five-fraction partial breast irradiation is currently recruiting; sponsor is Ontario Clinical Oncology Group.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Breast Neoplasm Female, Radiotherapy | Phase 3 | Status: RECRUITING